RPTX.Repare Therapeutics INC

Form 4: Repare Therapeutics EVP Michael Zinda Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4 Filing

📋All filings for Repare Therapeutics INC
🔒Login to Follow

Michael Zinda, EVP and Chief Scientific Officer of Repare Therapeutics, sold common shares between March 25 and March 27, 2024, to cover tax obligations related to vested restricted stock units.

Summary

  • Michael Zinda, the EVP and Chief Scientific Officer of Repare Therapeutics, sold a total of 1,350 common shares between March 25 and March 27, 2024.
  • The sales were executed to cover tax withholding obligations related to the vesting of restricted stock units (RSUs).
  • These transactions were made pursuant to a Rule 10b5-1 trading plan adopted on December 22, 2023.
  • The prices per share ranged from $4.52 to $4.91 across the three days of sales.
  • Following these transactions, Zinda still beneficially owns 72,768 common shares.

Sentiment

Score: 5

Explanation: The document describes routine transactions related to tax obligations, so the sentiment is neutral.

Industry Context

Sales of shares to cover tax obligations after RSU vesting are a common practice among company executives and do not necessarily indicate a negative outlook on the company's future.

Key Dates

DateDescription
January 30, 2023Holder was granted 24,550 restricted stock units (RSUs).
February 1, 2023Form 4 filed reporting the grant of 24,550 restricted stock units (RSUs).
December 22, 2023Rule 10b5-1 trading plan adopted by the holder.
January 30, 20248,183 of the RSUs vested.
March 25, 2024Sale of 450 common shares at a weighted average price of $4.78.
March 26, 2024Sale of 450 common shares at a weighted average price of $4.61.
March 27, 2024Sale of 450 common shares at a weighted average price of $4.62.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.